<DOC>
	<DOCNO>NCT00603031</DOCNO>
	<brief_summary>study hypothesis : treatment GLP-1 and/or GIP able potentiate maximal stimulate insulin secretion even c-peptide negative type-1 diabetic patient classify residual beta cell function leave .</brief_summary>
	<brief_title>Effect GLP-1 GIP Insulin Secretion Type-1 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Age 1860 year Type1 diabetes diagnose 540 year age Normal weight ( BMI 1827 ) , Insulin treatment time diagnosis . Severe complication diabetes Abnormal liver kidney function Haemoglobin low limit Macroalbuminuria Systemic disease Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>